Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,527 | 87,226 | 63,970 | 42,593 | 27,652 |
| Depreciation Amortization | 4,747 | 17,368 | 13,466 | 9,218 | 5,330 |
| Income taxes - deferred | 1,650 | 11,734 | 1,874 | 4,738 | 2,580 |
| Other Working Capital | 363,752 | -30,590 | 29,788 | -43,977 | 7,053 |
| Other Operating Activity | 900 | 9,753 | 7,434 | 5,351 | 5,794 |
| Operating Cash Flow | $376,576 | $95,491 | $116,532 | $17,923 | $48,409 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -380 | -2,683 | -2,151 | -1,779 | -737 |
| Net Acquisitions | N/A | -3,376 | N/A | N/A | N/A |
| Investing Cash Flow | $-380 | $-6,059 | $-2,151 | $-1,779 | $-737 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -37,531 | -35,131 | N/A | N/A |
| Common Stock Issued | 216 | 8,491 | 4,196 | 4,196 | 3,991 |
| Dividend Paid | -7,506 | -7,238 | -7,238 | -4,300 | -4,300 |
| Other Financing Activity | -24,650 | -28,164 | -28,164 | -28,164 | -28,164 |
| Financing Cash Flow | $-31,940 | $-64,442 | $-66,337 | $-28,268 | $-28,473 |
| Beginning Cash Position | 77,033 | 52,043 | 52,043 | 52,043 | 52,043 |
| End Cash Position | 421,289 | 77,033 | 100,087 | 39,919 | 71,242 |
| Net Cash Flow | $344,256 | $24,990 | $48,044 | $-12,124 | $19,199 |
| Free Cash Flow | |||||
| Operating Cash Flow | 376,576 | 95,491 | 116,532 | 17,923 | 48,409 |
| Capital Expenditure | -380 | -2,683 | -2,151 | -1,779 | -737 |
| Free Cash Flow | 376,196 | 92,808 | 114,381 | 16,144 | 47,672 |